73 related articles for article (PubMed ID: 15474473)
1. The roles of amino acid residues at positions 43 and 45 in microsomal contents and enzymatic functions of rat CYP2D1 and CYP2D2.
Narimatsu S; Imoto K; Isobe T; Kiryu K; Naito S; Hichiya H; Funae Y; Hanioka N; Yamamoto S
Biochem Biophys Res Commun; 2004 Nov; 324(2):627-33. PubMed ID: 15474473
[TBL] [Abstract][Full Text] [Related]
2. The roles of amino acid residues at positions 216 and 219 in the structural stability and metabolic functions of rat cytochrome P450 2D1 and 2D2.
Narimatsu S; Kiryu K; Yonemoto R; Yoshino M; Kobatake M; Kazamori D; Hagino S; Masuda K; Katsu T; Asanuma M; Kumamoto T; Ishikawa T; Funae Y; Yamano S; Hanioka N; Naito S
Chem Biol Interact; 2008 Mar; 172(1):11-21. PubMed ID: 18191824
[TBL] [Abstract][Full Text] [Related]
3. Catalytic specificity of CYP2D isoforms in rat and human.
Hiroi T; Chow T; Imaoka S; Funae Y
Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561
[TBL] [Abstract][Full Text] [Related]
4. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.
Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y
Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752
[TBL] [Abstract][Full Text] [Related]
5. Different effects of desipramine on bufuralol 1''-hydroxylation by rat and human CYP2D enzymes.
Isobe T; Hichiya H; Hanioka N; Yamamoto S; Shinoda S; Funae Y; Satoh T; Yamano S; Narimatsu S
Biol Pharm Bull; 2005 Apr; 28(4):634-40. PubMed ID: 15802801
[TBL] [Abstract][Full Text] [Related]
6. Complementary DNA cloning and characterization of cytochrome P450 2D29 from Japanese monkey liver.
Hichiya H; Takemi C; Tsuzuki D; Yamamoto S; Asaoka K; Suzuki S; Satoh T; Shinoda S; Kataoka H; Narimatsu S
Biochem Pharmacol; 2002 Oct; 64(7):1101-10. PubMed ID: 12234613
[TBL] [Abstract][Full Text] [Related]
7. Cloning and functional expression of a novel marmoset cytochrome P450 2D enzyme, CYP2D30: comparison with the known marmoset CYP2D19.
Hichiya H; Kuramoto S; Yamamoto S; Shinoda S; Hanioka N; Narimatsu S; Asaoka K; Miyata A; Iwata S; Nomoto M; Satoh T; Kiryu K; Ueda N; Naito S; Tucker GT; Ellis SW
Biochem Pharmacol; 2004 Jul; 68(1):165-75. PubMed ID: 15183128
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
John GH; Hasler JA; He YA; Halpert JR
Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
[TBL] [Abstract][Full Text] [Related]
9. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
[TBL] [Abstract][Full Text] [Related]
10. Role of residue 480 in substrate specificity of cytochrome P450 2B5 and 2B11.
Liu J; He YA; Halpert JR
Arch Biochem Biophys; 1996 Mar; 327(1):167-73. PubMed ID: 8615687
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2.
Yamamoto Y; Tasaki T; Nakamura A; Iwata H; Kazusaka A; Gonzalez FJ; Fujita S
Pharmacogenetics; 1998 Feb; 8(1):73-82. PubMed ID: 9511184
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression.
Schulz-Utermoehl T; Bennett AJ; Ellis SW; Tucker GT; Boobis AR; Edwards RJ
Pharmacogenetics; 1999 Jun; 9(3):357-66. PubMed ID: 10471068
[TBL] [Abstract][Full Text] [Related]
13. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.
Chow T; Imaoka S; Hiroi T; Funae Y
Drug Metab Dispos; 1999 Feb; 27(2):188-92. PubMed ID: 9929501
[TBL] [Abstract][Full Text] [Related]
14. Importance of CYP2D3 in polymorphism of diazepam p-hydroxylation in rats.
Sakai N; Saito K; Kim HS; Kazusaka A; Ishizuka M; Funae Y; Fujita S
Drug Metab Dispos; 2005 Nov; 33(11):1657-60. PubMed ID: 16081673
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of the CYP2D1-binding protein, retinol dehydrogenase.
Imaoka S; Wan J; Chow T; Hiroi T; Eyanagi R; Shigematsu H; Funae Y
Arch Biochem Biophys; 1998 May; 353(2):331-6. PubMed ID: 9606967
[TBL] [Abstract][Full Text] [Related]
16. The role of the length and sequence of the linker domain of cytochrome b5 in stimulating cytochrome P450 2B4 catalysis.
Clarke TA; Im SC; Bidwai A; Waskell L
J Biol Chem; 2004 Aug; 279(35):36809-18. PubMed ID: 15194706
[TBL] [Abstract][Full Text] [Related]
17. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1.
Duescher RJ; Elfarra AA
Arch Biochem Biophys; 1994 Jun; 311(2):342-9. PubMed ID: 8203896
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
19. The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol.
Narimatsu S; Kazamori D; Masuda K; Katsu T; Funae Y; Naito S; Nakura H; Yamano S; Hanioka N
Biochem Pharmacol; 2009 Mar; 77(5):920-31. PubMed ID: 19059219
[TBL] [Abstract][Full Text] [Related]
20. Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation.
He XY; Shen J; Hu WY; Ding X; Lu AY; Hong JY
Arch Biochem Biophys; 2004 Jul; 427(2):143-53. PubMed ID: 15196988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]